Verastem Inc

Financials

営業活動によるキャッシュフロー -33.51 M-53.5 M-63.67 M-86.46 M-104.77 M-137.51 M -137.51 M 投資活動によるキャッシュフロー -47.36 M87 K66.19 M-44.45 M59.97 M-9.62 M — 財務活動によるキャッシュフロー 69.63 M6.88 M51.78 M134.19 M54.78 M263.31 M 263.31 M フリーキャッシュフロー -33.54 M-53.7 M-63.67 M-86.46 M-104.8 M-147.13 M -137.51 M

Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index.

VSTM

Financials

Verastem Inc

ニュース

The 'Unprecedented' Cancer Test Results That Sent Revolution Medicines Flying

3 Best Stocks to Buy Today, 4/11/2026, According to Top Analysts - TipRanks.com

Cancer Stocks to Buy as Innovation Reshapes Global Oncology Market

Verastem: Maintaining "Buy" As 1st Half 2026 Catalysts In Play (NASDAQ:VSTM)

BTIGがVerastem株を買い推奨で開始、目標株価19ドル

Verastem stock initiated at Buy by BTIG with $19 price target

Wall Street Analysts See a 159.31% Upside in Verastem (VSTM): Can the Stock Really Move This High?

Jefferies、製品発売の進展を受けVerastem株の投資判断を維持

Jefferies reiterates Verastem stock rating on launch progress

Verastem, Inc. (VSTM) Q4 2025 Earnings Call Transcript

Verastem (VSTM) Reports Q4 Loss, Beats Revenue Estimates

3 Best Stocks With 125%+ Upside Ahead, According to Top Analysts, 3/2/2026 - TipRanks.com